This brochure provides a comprehensive overview of Ace Therapeutics' in vitro models and cell-based assay platforms for stroke research. We focus on timeliness and accuracy at every stage of development.
Download our brochure to discover how our in vitro models can accelerate your research and drive innovation in stroke therapies.
Our Capabilities
A systematic introduction to Ace Therapeutics' preclinical stroke research capabilities and cutting-edge technology platforms.
Ace Therapeutics provides customized stroke models and technology platforms to support preclinical stroke research.
The intraluminal filament tMCAO is a widely used experimental model to mimic focal cerebral ischemia followed by reperfusion, studying disease mechanisms and treatments.
Photochemical thrombosis is a method for the induction of ischemic stroke in the cerebral cortex, which aids in stroke mechanism and therapy development.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.